Literature DB >> 10893676

Cardiac L-type calcium channel alpha 1-subunit is increased by cyclic adenosine monophosphate: messenger RNA and protein expression in intact bone.

X T Wang1, S Nagaba, Y Nagaba, S W Leung, J Wang, W Qiu, P L Zhao, S E Guggino.   

Abstract

L-type calcium channels have been identified previously in both osteoblast-like osteosarcoma cell lines and primary cultures of osteoblasts using numerous techniques such as patch clamp recording, drug inhibited 45Ca2+ uptake, and Fura-2 measurements, but intact bone has not been investigated. Using reverse-transcription polymerase chain reaction (RT-PCR) we found that the three major isoforms of the alpha 1-subunit of L-type calcium channels, (alpha 1C, alpha 1D, and alpha 1S) are present in RNA extracted from ROS 17/2.8 osteosarcoma cells, rat femur, and rat skull. Sequencing of most of the alpha 1C-subunit from rat femur and ROS cells revealed that the splice variants in osteosarcoma cells and intact bone differ, but there are no unique sequence variations compared with those found in other tissues. Northern blot analysis of ROS cell RNA indicated that cyclic adenosine monophosphate (cAMP), but not 1 alpha, 25-dihydroxyvitamin D3, increased the messenger RNA (mRNA) of the alpha 1C-subunit. Western blot of ROS cell lysates revealed a band of more then 220 kDa, the amount of which increased in cells treated with cAMP. Using confocal microscopy combined with immunohistochemistry in ROS cells, intact bone, and cartilage, we found that the alpha 1C-subunit of this channel is expressed in osteoblasts and chondrocytes suggesting this channel may be a pathway for signal transduction in intact tissue, because it is in osteosarcoma cell lines and primary osteoblasts grown in tissue culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893676     DOI: 10.1359/jbmr.2000.15.7.1275

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

Review 1.  Regulation of chondrogenesis and chondrocyte differentiation by stress.

Authors:  Michael J Zuscik; Matthew J Hilton; Xinping Zhang; Di Chen; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 2.  Voltage-dependent calcium channels in chondrocytes: roles in health and disease.

Authors:  Csaba Matta; Róza Zákány; Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

3.  Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss.

Authors:  Chike Cao; Yinshi Ren; Adam S Barnett; Anthony J Mirando; Douglas Rouse; Se Hwan Mun; Kyung-Hyun Park-Min; Amy L McNulty; Farshid Guilak; Courtney M Karner; Matthew J Hilton; Geoffrey S Pitt
Journal:  JCI Insight       Date:  2017-11-16

4.  The CaV1.2 L-type calcium channel regulates bone homeostasis in the middle and inner ear.

Authors:  Chike Cao; Aaron B Oswald; Brian A Fabella; Yinshi Ren; Ramona Rodriguiz; George Trainor; Matthew B Greenblatt; Matthew J Hilton; Geoffrey S Pitt
Journal:  Bone       Date:  2019-05-20       Impact factor: 4.398

5.  L-type calcium channel activity in osteoblast cells is regulated by the actin cytoskeleton independent of protein trafficking.

Authors:  Fangping Li; Wenwei Wang; Ming Gu; Stefka Gyoneva; Jie Zhang; Shiying Huang; Stephen F Traynelis; Hui Cai; Sandra E Guggino; Xuemei Zhang
Journal:  J Bone Miner Metab       Date:  2011-01-19       Impact factor: 2.626

6.  Simulated microgravity inhibits L-type calcium channel currents partially by the up-regulation of miR-103 in MC3T3-E1 osteoblasts.

Authors:  Zhongyang Sun; Xinsheng Cao; Zhuo Zhang; Zebing Hu; Lianchang Zhang; Han Wang; Hua Zhou; Dongtao Li; Shu Zhang; Manjiang Xie
Journal:  Sci Rep       Date:  2015-01-28       Impact factor: 4.379

Review 7.  Skeletal Functions of Voltage Sensitive Calcium Channels.

Authors:  Christian S Wright; Alexander G Robling; Mary C Farach-Carson; William R Thompson
Journal:  Curr Osteoporos Rep       Date:  2021-03-15       Impact factor: 5.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.